Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2011 | 09-2010 | 09-2009 | 09-2008 | 09-2007 | |
| Sales | 4,821 | 0 | 0 | 0 | 0 |
| Gross Profit | 4,821 | N/A | N/A | N/A | N/A |
| Operating Expenses | 8,723 | 3,644 | 2,003 | 2,517 | 3,300 |
| Operating Income | -3,902 | -3,644 | -2,003 | -2,517 | -3,300 |
| Interest Expense | 21 | 878 | 441 | 93 | 51 |
| Other Income | 4,222 | -21,347 | 148 | -363 | 327 |
| Pre-tax Income | 299 | -25,869 | -2,296 | -2,973 | -3,024 |
| Net Income Continuous | 299 | -25,869 | -2,296 | -2,973 | -3,024 |
| Net Income | $299 | $-25,869 | $-2,296 | $-2,973 | $-3,024 |
| EPS Basic Total Ops | 0.00 | -0.53 | -0.07 | -0.09 | -0.10 |
| EPS Basic Continuous Ops | 0.01 | -0.53 | -0.07 | -0.09 | -0.10 |
| EPS Diluted Total Ops | -0.04 | -0.53 | -0.07 | -0.11 | -0.10 |
| EPS Diluted Continuous Ops | 0.00 | -0.53 | -0.07 | -0.09 | -0.10 |
| EBITDA(a) | $-3,897 | $-3,643 | $-2,003 | $-2,517 | $-3,300 |